Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection
Open Access
- 29 December 2020
- journal article
- review article
- Published by Elsevier BV in Journal of Traditional and Complementary Medicine
- Vol. 11 (2), 144-157
- https://doi.org/10.1016/j.jtcme.2020.12.001
Abstract
No abstract availableKeywords
Funding Information
- Chulalongkorn University
This publication has 115 references indexed in Scilit:
- Curcumin and Its Carbocyclic Analogs: Structure-Activity in Relation to Antioxidant and Selected Biological PropertiesMolecules, 2013
- [6]-Gingerol: A Novel AT1 Antagonist for the Treatment of Cardiovascular DiseasePlanta Medica, 2013
- Phenolic‐Linked Biochemical Rationale for the Anti‐Diabetic Properties of Swertia chirayita (Roxb. ex Flem.) Karst.Phytotherapy Research, 2012
- Anti-Inflammatory and Free Radial Scavenging Activities of the Constituents Isolated from Machilus zuihoensisMolecules, 2011
- Comparative Evaluation of Two Structurally Related Flavonoids, Isoliquiritigenin and Liquiritigenin, for Their Oral Infection Therapeutic PotentialJournal of Natural Products, 2011
- Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell CulturePLoS Pathogens, 2010
- Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infectionAntiviral Research, 2009
- Antiviral Activity of the Zinc Ionophores Pyrithione and Hinokitiol against Picornavirus InfectionsJournal of Virology, 2009
- Clathrin-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus into Target Cells Expressing ACE2 with the Cytoplasmic Tail DeletedJournal of Virology, 2007
- Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus releaseProceedings of the National Academy of Sciences of the United States of America, 2006